UQ’s reputation for excellence and innovation is reflected in every facet of Australian health, medical, behavioural and biomedical sciences research.

UQ conceived Australia's first blockbuster vaccine Gardasil®. The internationally acclaimed Triple P Positive Parenting Program emerged from our School of Psychology. UQ’s pain therapeutics start-up QRxPharma Ltd made Australian Stock exchange history as the largest biotech IPO, and UQ’s superconductor technology is now used in two-thirds of the world's MRI machines.

Confidence in our capability to deliver outcomes – a solid return on research investment – is high, nationally and internationally.

That’s why we’ve received unprecedented public funding through the Australian Research Council and the National Health and Medical Research Council NHMRC), as well as other state and federal government sources and international entities such as the Bill and Melinda Gates Foundation.

And we are able to leverage this confidence and our enviable track record to attract support from the community organisations and private ventures which share our goals for better health through research.

  • The NHMRC awared UQ Researchers more than $8 million to fund research into musculoskeletal conditions. 
  • In 2013 the NHMRC awarded UQ $51 million to pursue discoveries relating to  cystic fibrosis, respiratory illness in Indigenous children, and chronic kidney disease.
  • With $11 million from the Queensland Government and the estate of Clem Jones, former Lord Mayor of Brisbane, we’re learning more about dementia and Alzheimer’s disease.
  • We’re hosting the Queensland node of Therapeutic Innovation Australia (TIA) with $6.9 million from the Australian Government and $2 million from the Queensland Government to accelerate the translation of Australian research discoveries into commercial therapeutic products.
  • The Australian Cancer Research Foundation is helping us targeted cancer detection and treatment programs with $4 million in support, while $3 million from the TB Sailors’, Soldiers’ and Airmen’s Association of Queensland (TB Association) is boosting tuberculosis research.
  • Our scientists are studying the genes associated with debilitating arthritis diseases like ankylosing spondylitis, thanks to US$4 million from the American National Institute of Arthritis and Musculoskeletal and Skin Diseases. At the same time, UQ Diamantina Institute researchers are working on rheumatoid arthritis, helped by a $1.25 million Premier’s Science Fellowship.

Our award-winning life scientists and clinicians collaborate with teams in Australia and overseas to find new chronic disease prevention and treatment models. Our population health, social work and human services researchers measure and monitor health impacts to ensure economic, social and health policy at all levels responds  effectively to diverse and changing community needs.

From head to toe, from prenatal to palliative care, UQ’s research is making a difference. Read more about our research strengths. See more of UQ’s discovery achievements. Learn more about UQ’s research impact.